Literature DB >> 2384924

Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1.

S J Arrigo1, S Weitsman, J A Zack, I S Chen.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) expresses the Vif, Vpr, Vpu, and Env proteins through complex differential splicing of a single full-length RNA precursor. We used HIV-1-specific oligonucleotide primer pairs in a quantitative polymerase chain reaction procedure on RNA from fresh peripheral blood lymphocytes infected with HIV-1JR-CSF to detect and characterize the singly spliced RNA species which might encode these proteins. The nucleotide sequences at the junctions of splice donor and acceptor sites of these RNAs were determined. One of these RNAs, which has not been previously described, appears to be a novel HIV-1 RNA encoding Env and/or Vpu proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384924      PMCID: PMC247934     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

2.  Nucleotide sequence of the AIDS virus, LAV.

Authors:  S Wain-Hobson; P Sonigo; O Danos; S Cole; M Alizon
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

3.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.

Authors:  M A Muesing; D H Smith; C D Cabradilla; C V Benton; L A Lasky; D J Capon
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

4.  The HIV 'A' (sor) gene product is essential for virus infectivity.

Authors:  K Strebel; D Daugherty; K Clouse; D Cohen; T Folks; M A Martin
Journal:  Nature       Date:  1987 Aug 20-26       Impact factor: 49.962

5.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor.

Authors:  M R Sadaie; J Rappaport; T Benter; S F Josephs; R Willis; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method.

Authors:  S J Arrigo; S Weitsman; J D Rosenblatt; I S Chen
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome.

Authors:  Z Matsuda; M J Chou; M Matsuda; J H Huang; Y M Chen; R Redfield; K Mayer; M Essex; T H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

9.  Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR.

Authors:  N Ahmad; S Venkatesan
Journal:  Science       Date:  1988-09-16       Impact factor: 47.728

10.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

Authors:  S K Arya; C Guo; S F Josephs; F Wong-Staal
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

View more
  33 in total

1.  Analysis of the transcription pattern and mapping of the putative rev and env splice junctions of bovine immunodeficiency-like virus.

Authors:  M S Oberste; J D Greenwood; M A Gonda
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures.

Authors:  W Muranyi; R M Flügel
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.

Authors:  Anna Tranell; Eva Maria Fenyö; Stefan Schwartz
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

4.  Characterization of multiple mRNA species of simian immunodeficiency virus from macaques in a CD4+ lymphoid cell line.

Authors:  I W Park; R Steen; Y Li
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.

Authors:  R Rosin-Arbesfeld; M Rivlin; S Noiman; P Mashiah; A Yaniv; T Miki; S R Tronick; A Gazit
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs.

Authors:  S Schwartz; B K Felber; E M Fenyö; G N Pavlakis
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages.

Authors:  Secondo Sonza; Helen P Mutimer; Kate O'Brien; Philip Ellery; Jane L Howard; Jonathan H Axelrod; Nicholas J Deacon; Suzanne M Crowe; Damian F J Purcell
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat.

Authors:  Walter Royal; Huiyun Wang; Odell Jones; Hieu Tran; Joseph L Bryant
Journal:  J Neuroimmunol       Date:  2007-02-07       Impact factor: 3.478

9.  Potent inhibition of HIV-1 replication by a Tat mutant.

Authors:  Luke W Meredith; Haran Sivakumaran; Lee Major; Andreas Suhrbier; David Harrich
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

10.  Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences.

Authors:  Christoph T Berger; Jonathan M Carlson; Chanson J Brumme; Kari L Hartman; Zabrina L Brumme; Leah M Henry; Pamela C Rosato; Alicja Piechocka-Trocha; Mark A Brockman; P Richard Harrigan; David Heckerman; Daniel E Kaufmann; Christian Brander
Journal:  J Exp Med       Date:  2010-01-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.